London - University College London
University College London (UCL) is committed to performing world-class clinical cancer research to develop new cancer therapies and undertake early phase clinical trials that are fully informed by modern molecular and imaging technologies. There is particular expertise and dedicated facilities for trials of antibody-targeted, radiation, photodynamic and vascular therapies and biomedical informatics.
Clinical Focus Area
- Medical Oncology
- Antibody targeted therapy
- Small molecule drug development
- Cellular therapy
- Gene therapy
Scientific Focus Area
- Antibody engineering
- Molecular diagnostics
- Circulating tumour cells
- DNA interactive agents
- T cell responses
- DNA Ploidy
- Pharmacokinetics & Pharmacodynamics
- Drug Discovery
Disease Focus Area
|Ovarian||Pancreatic||Sarcoma||Relevant to all Types of Cancer|
For further information on the goals and objectives of UCL ECMC go to:
UCL ECMC principal investigators and staff have a diverse range of skills and expertise.
UCL ECMC has access to a range of research facilities that are utilised in studies.